๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Parkinson Disease (PD)
Clinical trial register · China

Parkinson Disease (PD) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Shanghai 3 Guangzhou 2 Nanjing 2 Changsha 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Shanghai3 Guangzhou2 Nanjing2 Changsha2
All 10 locations
Target enrolment
to

Parkinson Disease (PD) trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
NCT07721688Parkinson Disease (PD)
Ke Dong, MD
Not applicable
40
Guangzhou
2026-07-20
Recruiting
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
NCT07725562Parkinson Disease (PD)
Zhejiang Vimgreen Pharmaceuticals, Ltd.
Phase 2/3
152
Beijing
2026-07-17
Not yet open
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations
NCT07414290Parkinson Disease (PD)
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 1/2
17
Changsha
2026-05-25
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Not yet open
A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History Study
NCT07588763Parkinson Disease (PD)
Fujian Medical University Union Hospital
Observational
3,000
Fujian
2026-04-28
Recruiting
Remote Ischemic Conditioning for Sleep Disturbances and Other Non-motor Symptoms in Parkinson's Disease
NCT07299240Parkinson Disease (PD), Insomnia
Jiangsu Province Nanjing Brain Hospital
Not applicable
48
Nanjing
2026-01-01
Recruiting
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
NCT07157345Parkinson Disease (PD)
Ruijin Hospital
Phase 1
12
Shanghai
2025-10-20
Recruiting
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
NCT07166757Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
90
Shanghai
2025-09-22
Not yet open
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
NCT07085195Parkinson Disease (PD), Gene Therapy, Safety and Efficacy, Clozapine
Ruijin Hospital
Phase EARLY_PHASE1
6
Shanghai
2025-08-01
Not yet open
The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease
NCT07028632Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd.
Phase 2
30
Beijing
2025-06-30
Recruiting
AI-Enhanced Optimization of Acute Levodopa Challenge Test
NCT06949865Vascular Parkinsonism, Drug-induced Parkinsonism, Corticobasal Degeneration (CBD), Parkinson Disease (PD)
Beijing Tiantan Hospital
Observational
2,000
Beijing
2024-05-28
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/parkinson-disease-pd

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Parkinson Disease (PD).

How many Parkinson Disease (PD) trials are recruiting in China?

8 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Parkinson Disease (PD)), 12 studies
PhaseStudiesRecruitingShare
Not applicable3325%
Observational3225%
Phase 1/22116.7%
Phase 1118.3%
Phase 2108.3%
Phase 2/3118.3%
Phase EARLY_PHASE1108.3%

Most active sponsors

Lead sponsors with the most studies (Parkinson Disease (PD))
Lead sponsorStudiesRecruiting
Ruijin Hospital21
Beijing Pins Medical Co., Ltd11
Beijing Tiantan Hospital11
Fujian Medical University Union Hospital10
iRegene Therapeutics Co., Ltd.10
Jiangsu Province Nanjing Brain Hospital11
Ke Dong, MD11
Shanghai Vitalgen BioPharma Co., Ltd.10
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.11
Yousheng Xiao11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.